Leucine-Rich Alpha-2 Glycoprotein as a Useful Biomarker for Monitoring Endoscopic and Histological Activity in Ulcerative Colitis
Journal of Clinical Medicine · 20.11.2026 · 15 (22) · 9121
DOI: 10.3390/jcm15229121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 20.11.2026. Verfasst von Tomoaki Tsuchiya und 8 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Serum leucine-rich alpha-2 glycoprotein (LRG) has been proposed as a biomarker of inflammatory activity in ulcerative colitis (UC). This study investigated the associations of serum LRG with endoscopic and histological disease activity and their longitudinal changes.
Methods
Thirty-six patients with UC who underwent two colonoscopies with biopsies were retrospectively evaluated. Correlations between serum LRG and the Ulcerative Colitis Endoscopic Index of Severity (UCEIS), Geboes scoring system (GS), and GS subgrades were assessed at the most inflamed site and across six colonic segments. Associations between longitudinal changes (Δ) were also evaluated.
Results
Serum LRG showed moderate correlations with UCEIS at the most inflamed site (r = 0.480) and across the entire colon (r = 0.510). LRG showed a weak but significant correlation with GS at the most inflamed site (r = 0.355), whereas its correlation with total GS was weak and non-significant (r = 0.324). Across six colonic segments, LRG showed moderate correlations with GS Grades 0, 1, 2B, and 3. ΔLRG showed moderate correlations with Δtotal UCEIS (r = 0.575), Δtotal GS (r = 0.458), and changes in Grades 0, 1, 2B, and 3 across the entire colon (r = 0.488–0.578).
Conclusions
Longitudinal changes in serum LRG were associated with changes in endoscopic and histological disease activity, particularly with whole-colon histological inflammation involving neutrophil-related GS subgrades. Further validation in larger cohorts is warranted.
Zitieren
APA
Tsuchiya, T., Hirayama, A., Ikeuchi, H., Sawaguchi, H., Kako, S., Okamura, T., Iwaya, Y., Iwaya, M., & Nagaya, T. (2026). Leucine-Rich Alpha-2 Glycoprotein as a Useful Biomarker for Monitoring Endoscopic and Histological Activity in Ulcerative Colitis. Journal of Clinical Medicine, 15(22), 9121. https://doi.org/10.3390/jcm15229121
Vancouver
Tsuchiya T, Hirayama A, Ikeuchi H, Sawaguchi H, Kako S, Okamura T, et al. Leucine-Rich Alpha-2 Glycoprotein as a Useful Biomarker for Monitoring Endoscopic and Histological Activity in Ulcerative Colitis. Journal of Clinical Medicine. 2026;15(22):9121. doi:10.3390/jcm15229121
BibTeX
@article{Tsuchiya2026,
author = {Tsuchiya, Tomoaki and Hirayama, Atsuhiro and Ikeuchi, Hiroshi and Sawaguchi, Hiroshi and Kako, Satoko and Okamura, Takuma and Iwaya, Yugo and Iwaya, Mai and Nagaya, Tadanobu},
title = {Leucine-Rich Alpha-2 Glycoprotein as a Useful Biomarker for Monitoring Endoscopic and Histological Activity in Ulcerative Colitis},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {22},
pages = {9121},
doi = {10.3390/jcm15229121}
}
EUVIMED